These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18187937)

  • 21. [Bone marrow hematopoiesis in those who worked in the cleanup of the aftermath of the accident at the Chernobyl Atomic Electric Power Station with a history of acute radiation sickness (based on myelogram data)].
    Klimenko SV
    Lik Sprava; 1999; (1):25-7. PubMed ID: 10423988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic effect of rmIL-12 combined with G-CSF on acute radiation sickness produced by γ-ray irradiation in mice].
    Wang L; Zhai RR; Pang ZX; Zhang C; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):995-9. PubMed ID: 22931671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study.
    Masucci G; Broman P; Kelly C; Lindahl S; Malmberg L; Reizenstein J; Alenius M; Lewensohn R
    Med Oncol; 2005; 22(3):247-56. PubMed ID: 16110136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
    Fan D; O'Brian CA; Ioannides CG; Clyne RK
    In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN; Papadopoulos NE; Chawla SP; Fenoglio C; Cooper S; Buescher ES; Frenck RW; Holian A
    J Clin Oncol; 1992 Aug; 10(8):1266-77. PubMed ID: 1634916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiological accident and incident in Thailand: lesson to be learned.
    Ya-anant N; Tiyapun K; Saiyut K
    Radiat Prot Dosimetry; 2011 Jul; 146(1-3):111-4. PubMed ID: 21561942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.
    Ho AD; Glück S; Germond C; Sinoff C; Dietz G; Maruyama M; Corringham RE
    Leukemia; 1993 Nov; 7(11):1738-46. PubMed ID: 7901454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Case of acute radiation sickness developed after general uniform gamma-ray irradiation (Co60)].
    Baranov AE; Petrosian LN; Piatkin EK; Drutman RD; Dorofeeva EM
    Med Radiol (Mosk); 1977 Aug; 22(8):48-55. PubMed ID: 927062
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early-response biomarkers for assessment of radiation exposure in a mouse total-body irradiation model.
    Ossetrova NI; Condliffe DP; Ney PH; Krasnopolsky K; Hieber KP; Rahman A; Sandgren DJ
    Health Phys; 2014 Jun; 106(6):772-86. PubMed ID: 24776912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine therapy in canine and primate models of radiation-induced marrow aplasia.
    MacVittie TJ; Monroy RL; Farese AM; Patchen ML; Seiler FR; Williams D
    Behring Inst Mitt; 1991 Dec; (90):1-13. PubMed ID: 1724900
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.
    de Vries EG; Biesma B; Willemse PH; Mulder NH; Stern AC; Aalders JG; Vellenga E
    Cancer Res; 1991 Jan; 51(1):116-22. PubMed ID: 1988077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor.
    Monroy RL; Skelly RR; Taylor P; Dubois A; Donahue RE; MacVittie TJ
    Exp Hematol; 1988 Jun; 16(5):344-8. PubMed ID: 3286278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role of granulocyte-macrophage colony stimulating factor (GM-CSF) in cancer chemotherapy.
    Cebon JS; Morstyn G
    Cancer Surv; 1990; 9(1):131-55. PubMed ID: 2276111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New clinical applications of granulocyte-macrophage colony-stimulating factor.
    Masucci G
    Med Oncol; 1996 Sep; 13(3):149-54. PubMed ID: 9106173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.